192 related articles for article (PubMed ID: 17725101)
1. Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence.
Yanagawa T; Yoshida H; Yamagata K; Onizawa K; Tabuchi K; Koyama Y; Iwasa S; Shimoyamada H; Harada H; Omura K
J Exp Clin Cancer Res; 2007 Jun; 26(2):215-20. PubMed ID: 17725101
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.
Yanagawa T; Omura K; Harada H; Ishii T; Uwayama J; Nakaso K; Iwasa S; Koyama Y; Onizawa K; Yusa H; Yoshida H
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):915-20. PubMed ID: 15955662
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue.
Matsuzaki H; Shima K; Muramatsu T; Ro Y; Hashimoto S; Shibahara T; Shimono M
J Oral Pathol Med; 2007 Jan; 36(1):30-4. PubMed ID: 17181739
[TBL] [Abstract][Full Text] [Related]
4. Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue.
Ulanovski D; Stern Y; Roizman P; Shpitzer T; Popovtzer A; Feinmesser R
Oral Oncol; 2004 May; 40(5):532-7. PubMed ID: 15006627
[TBL] [Abstract][Full Text] [Related]
5. Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis.
Silveira EJ; Godoy GP; Lins RD; Arruda Mde L; Ramos CC; Freitas Rde A; Queiroz LM
Int J Surg Pathol; 2007 Oct; 15(4):376-83. PubMed ID: 17913944
[TBL] [Abstract][Full Text] [Related]
6. Expression of cIAP-1 correlates with nodal metastasis in squamous cell carcinoma of the tongue.
Qi S; Mogi S; Tsuda H; Tanaka Y; Kozaki K; Imoto I; Inazawa J; Hasegawa S; Omura K
Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1047-53. PubMed ID: 18621506
[TBL] [Abstract][Full Text] [Related]
7. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF).
Cho JH; Kim HS; Park CS; Kim JK; Jung KY; Shin BK; Kim HK
Oral Oncol; 2007 Mar; 43(3):272-7. PubMed ID: 17174141
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression in the squamous cell carcinoma of the tongue base.
Rabkin D; Chhieng DC; Miller MB; Jennings T; Feustel P; Steiniger J; Parnes SM
Laryngoscope; 1995 Dec; 105(12 Pt 1):1294-9. PubMed ID: 8523980
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.
Honjo Y; Inohara H; Akahani S; Yoshii T; Takenaka Y; Yoshida J; Hattori K; Tomiyama Y; Raz A; Kubo T
Clin Cancer Res; 2000 Dec; 6(12):4635-40. PubMed ID: 11156213
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
[TBL] [Abstract][Full Text] [Related]
11. Clinocopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions.
Ono Y; Nakanishi Y; Ino Y; Niki T; Yamada T; Yoshimura K; Saikawa M; Nakajima T; Hirohashi S
Cancer; 1999 Jun; 85(11):2315-21. PubMed ID: 10357399
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin expression profiling is useful for distinguishing between primary squamous cell carcinoma of the lung and pulmonary metastases from tongue cancer.
Ohba T; Motoi N; Kimura Y; Okumura S; Kawabata K; Yoshizawa Y; Inase N; Ishikawa Y
Pathol Int; 2010 Aug; 60(8):575-80. PubMed ID: 20618735
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of c-erbB-2 (HER-2/neu) in squamous cell carcinoma of the tongue: does over-expression exist? And what is its correlation with traditional diagnostic parameters?
Angiero F; Sordo RD; Dessy E; Rossi E; Berenzi A; Stefani M; Sidoni A
J Oral Pathol Med; 2008 Mar; 37(3):145-50. PubMed ID: 18251938
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of metallothionein and p53 expression as potential prognostic markers for laryngeal squamous cell carcinoma.
Brown JJ; Xu H; William-Smith L; Mohamed H; Teklehaimanot S; Zhuo J; Osborne R; Liu F; Gowans RE; Nishitani J; Liu X
Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL473-9. PubMed ID: 14995078
[TBL] [Abstract][Full Text] [Related]
15. Association of tumor satellite distance with prognosis and contralateral neck recurrence of tongue squamous cell carcinoma.
Yang TL; Wang CP; Ko JY; Lin CF; Lou PJ
Head Neck; 2008 May; 30(5):631-8. PubMed ID: 18213729
[TBL] [Abstract][Full Text] [Related]
16. EMMPRIN expression in tongue squamous cell carcinoma.
Huang Z; Huang H; Li H; Chen W; Pan C
J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
[TBL] [Abstract][Full Text] [Related]
17. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
[TBL] [Abstract][Full Text] [Related]
19. In situ adenocarcinoma and squamous carcinoma of uterine cervix. Pathological and immunohistochemical analysis with cytokeratin 13.
Raspollini MR; Fambrini M; Marchionni M; Baroni G; Taddei GL
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):249-53. PubMed ID: 16949723
[TBL] [Abstract][Full Text] [Related]
20. Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung.
Saijo T; Ishii G; Nagai K; Funai K; Nitadori J; Tsuta K; Nara M; Hishida T; Ochiai A
Lung Cancer; 2006 Apr; 52(1):37-45. PubMed ID: 16497410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
